Synairgen plc (LON:SNG – Get Rating) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 14.31 ($0.18) and traded as low as GBX 9.50 ($0.12). Synairgen shares last traded at GBX 9.50 ($0.12), with a volume of 377,264 shares trading hands.
Synairgen Stock Performance
The company has a debt-to-equity ratio of 0.09, a current ratio of 6.35 and a quick ratio of 6.35. The stock has a 50 day simple moving average of GBX 10.58 and a two-hundred day simple moving average of GBX 14.31. The company has a market cap of £19.13 million, a PE ratio of -55.88 and a beta of -2.29.
Synairgen Company Profile
(Get Rating)
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
Featured Stories
- How to Invest in the Top Grocery Stocks for This Year
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- ExxonMobil Gushes To New Highs
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.